- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05419245
Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome (FINDFSS)
Findings, Diagnostic Accuracy, Treatment, and Outcomes in Freeman-Burian Syndrome and Similar-appearing Arthrogryposis Syndromes: a Cross-sectional, Non-randomized Study
The purpose of this study is to evaluate the difference in diagnosis accuracy, treatment outcomes, patient perspectives, facial function and walking ability, emotional and social health, and respiratory complications between Freeman-Burian syndrome (formerly, Freeman-Sheldon or whistling face syndrome), Sheldon-Hall syndrome, and distal arthrogryposis types 3, and 1.
The approximate cumulative total time for study-related activities will be 3 hours, including email communication, survey completion, and a medical interview.
The study will involve completing 6 short ½ to 1-page surveys and participating in a medical interview. Participants may be asked to provide medical records for review. All study-related activities will take place remotely, and no travel is required.
Study Overview
Status
Conditions
Intervention / Treatment
- Other: Guided Health History for Freeman-Burian Syndrome Questionnaire
- Other: Freeman-Burian syndrome Semi-Structured Quality of Life Interview
- Other: Medical Records Review
- Other: PTSD Checklist for DSM-5
- Other: Modified Flanagan Quality of Life Scale
- Other: Center for Epidemiologic Studies Depression Scale
- Other: Review of Systems
- Other: FACE-Q | Craniofacial - Appearance of the Face
- Other: FACE-Q | Craniofacial - Appearance Distress
- Other: FACE-Q | Craniofacial - Facial Function
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Craig R Dufresne, MD
- Phone Number: 7032073065
- Email: info@duplastics.com
Study Contact Backup
- Name: Mikaela I Poling, BA
- Phone Number: 3044609038
- Email: research@duplastics.com
Study Locations
-
-
Virginia
-
Fairfax, Virginia, United States, 22031
- Recruiting
- Office of Craig R Dufresne, MD, PC
-
Contact:
- Craig R Dufresne, MD
- Phone Number: 703-207-3065
- Email: info@duplastics.com
-
Contact:
- Mikaela I Poling, BA
- Phone Number: 703-207-3065
- Email: research@duplastics.com
-
Principal Investigator:
- Craig R Dufresne, MD
-
Sub-Investigator:
- Mikaela I Poling, BA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who are able to provide informed consent or have a legally appointed representative who is able to provide informed consent
- Patients who have Freeman-Burian syndrome (formerly, Freeman-Sheldon syndrome), Sheldon-Hall syndrome, distal arthrogryposis type 1, or distal arthrogryposis type 3
- Persons who speak and read English, German, Russian, or Czech
Exclusion Criteria:
- Patients who are not able to provide informed consent or do not have a legally appointed representative who is able to provide informed consent
- Patients who do not have Freeman-Burian syndrome (formerly, Freeman-Sheldon syndrome), Sheldon-Hall syndrome, distal arthrogryposis type 1, or distal arthrogryposis type 3
- Persons who do not speak or read English, German, Russian, or Czech
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Freeman-Sheldon syndrome Classic Type
Patients who have all features required by the Stevenson criteria, including: very small mouth (microstomia); whistling-face appearance (pursed lips); "H" or "V" shaped chin dimple; very obvious down-slanting crease from the nostril to the corners of the mouth (nasolabial creases); and restricted movement in joints (contractures) of two or more body areas, often hands and feet, with fingers and toes frequently overlapping.
|
Completed during the interview.
The Guided Health History for Freeman-Burian Syndrome Questionnaire is a guided interview form that will be used to assess diagnosis, problems, treatments, and outcomes.
Completed during the interview.
Freeman-Burian syndrome Semi-Structured Quality of Life Interview is a quality of life interview for Freeman-Burian syndrome, taking into consideration individual's total health.
Review of medical records will be used, along with Guided Health History for Freeman-Burian Syndrome Questionnaire to assess patient histories and outcomes.
Other Names:
Completed by patients before the interview.
The PTSD Checklist for DSM-5 is a 20-item questionnaire.
Each item is rated 0-4, with 0 being "Not at all" and 4 being "Extremely".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed by patients before the interview.
The Modified Flanagan Quality of Life Scale is a 16-item survey designed for use in persons with chronic illness.
Each item is rated 1-7, with 1 being "Terrible" and 7 being "Delighted".
Higher scores suggest the person may be experiencing a better quality of life.
Completed by patients before the interview.
The Center for Epidemiologic Studies Depression Scale is a 20-item survey that asks about depressive feelings and behaviours in the past week.
Each item is rated 0-3, with 0 being "Rarely or none of the time (less than 1 day)" and 3 being "Most or all of the time (5-7 days)".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed during the interview.
A review of systems is a checklist of medical problems.
Other Names:
Completed by patients.
The FACE-Q | Craniofacial - Appearance of the Face is a 9-item questionnaire.
Each item is rated 1-4, with 1 being "Not at All" and 4 being "Very Much".
Lower scores suggest the person may be less pleased with the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Appearance Distress is an 8-item questionnaire.
Each item is rated 1-4, with 1 being "Always" and 4 being "Never".
Lower scores suggest the person may be experiencing more distress related to the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Facial Function is a 10-item questionnaire.
Each item is rated 1-3, with 1 being "I cannot do this" and 3 being "I can do this".
Lower scores suggest the person may be experiencing more problems with facial muscle functioning.
|
Freeman-Sheldon syndrome Craniofacial Type
Patients who have only the face and skull physical findings required by the Stevenson criteria, including: very small mouth (microstomia), whistling-face appearance (pursed lips), "H" or "V" shaped chin dimple, very obvious down-slanting crease from the nostril to the corners of the mouth (nasolabial creases).
|
Completed during the interview.
The Guided Health History for Freeman-Burian Syndrome Questionnaire is a guided interview form that will be used to assess diagnosis, problems, treatments, and outcomes.
Completed during the interview.
Freeman-Burian syndrome Semi-Structured Quality of Life Interview is a quality of life interview for Freeman-Burian syndrome, taking into consideration individual's total health.
Review of medical records will be used, along with Guided Health History for Freeman-Burian Syndrome Questionnaire to assess patient histories and outcomes.
Other Names:
Completed by patients before the interview.
The PTSD Checklist for DSM-5 is a 20-item questionnaire.
Each item is rated 0-4, with 0 being "Not at all" and 4 being "Extremely".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed by patients before the interview.
The Modified Flanagan Quality of Life Scale is a 16-item survey designed for use in persons with chronic illness.
Each item is rated 1-7, with 1 being "Terrible" and 7 being "Delighted".
Higher scores suggest the person may be experiencing a better quality of life.
Completed by patients before the interview.
The Center for Epidemiologic Studies Depression Scale is a 20-item survey that asks about depressive feelings and behaviours in the past week.
Each item is rated 0-3, with 0 being "Rarely or none of the time (less than 1 day)" and 3 being "Most or all of the time (5-7 days)".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed during the interview.
A review of systems is a checklist of medical problems.
Other Names:
Completed by patients.
The FACE-Q | Craniofacial - Appearance of the Face is a 9-item questionnaire.
Each item is rated 1-4, with 1 being "Not at All" and 4 being "Very Much".
Lower scores suggest the person may be less pleased with the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Appearance Distress is an 8-item questionnaire.
Each item is rated 1-4, with 1 being "Always" and 4 being "Never".
Lower scores suggest the person may be experiencing more distress related to the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Facial Function is a 10-item questionnaire.
Each item is rated 1-3, with 1 being "I cannot do this" and 3 being "I can do this".
Lower scores suggest the person may be experiencing more problems with facial muscle functioning.
|
Freeman-Sheldon syndrome Mixed Type
Patients who have the face and skull physical findings required by the Stevenson criteria and some but not all required joint problems.
|
Completed during the interview.
The Guided Health History for Freeman-Burian Syndrome Questionnaire is a guided interview form that will be used to assess diagnosis, problems, treatments, and outcomes.
Completed during the interview.
Freeman-Burian syndrome Semi-Structured Quality of Life Interview is a quality of life interview for Freeman-Burian syndrome, taking into consideration individual's total health.
Review of medical records will be used, along with Guided Health History for Freeman-Burian Syndrome Questionnaire to assess patient histories and outcomes.
Other Names:
Completed by patients before the interview.
The PTSD Checklist for DSM-5 is a 20-item questionnaire.
Each item is rated 0-4, with 0 being "Not at all" and 4 being "Extremely".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed by patients before the interview.
The Modified Flanagan Quality of Life Scale is a 16-item survey designed for use in persons with chronic illness.
Each item is rated 1-7, with 1 being "Terrible" and 7 being "Delighted".
Higher scores suggest the person may be experiencing a better quality of life.
Completed by patients before the interview.
The Center for Epidemiologic Studies Depression Scale is a 20-item survey that asks about depressive feelings and behaviours in the past week.
Each item is rated 0-3, with 0 being "Rarely or none of the time (less than 1 day)" and 3 being "Most or all of the time (5-7 days)".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed during the interview.
A review of systems is a checklist of medical problems.
Other Names:
Completed by patients.
The FACE-Q | Craniofacial - Appearance of the Face is a 9-item questionnaire.
Each item is rated 1-4, with 1 being "Not at All" and 4 being "Very Much".
Lower scores suggest the person may be less pleased with the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Appearance Distress is an 8-item questionnaire.
Each item is rated 1-4, with 1 being "Always" and 4 being "Never".
Lower scores suggest the person may be experiencing more distress related to the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Facial Function is a 10-item questionnaire.
Each item is rated 1-3, with 1 being "I cannot do this" and 3 being "I can do this".
Lower scores suggest the person may be experiencing more problems with facial muscle functioning.
|
Sheldon-Hall syndrome
Patients who have all features required by the Stevenson criteria, including: small mouth (not microstomia); neck webbing (pterygium colli); small but prominent chin; very obvious down-slanting crease from the nostril to the corners of the mouth (nasolabial creases); and restricted movement in joints (contractures) of two or more body areas, often hands and feet, with fingers and toes frequently overlapping.
|
Completed during the interview.
The Guided Health History for Freeman-Burian Syndrome Questionnaire is a guided interview form that will be used to assess diagnosis, problems, treatments, and outcomes.
Completed during the interview.
Freeman-Burian syndrome Semi-Structured Quality of Life Interview is a quality of life interview for Freeman-Burian syndrome, taking into consideration individual's total health.
Review of medical records will be used, along with Guided Health History for Freeman-Burian Syndrome Questionnaire to assess patient histories and outcomes.
Other Names:
Completed by patients before the interview.
The PTSD Checklist for DSM-5 is a 20-item questionnaire.
Each item is rated 0-4, with 0 being "Not at all" and 4 being "Extremely".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed by patients before the interview.
The Modified Flanagan Quality of Life Scale is a 16-item survey designed for use in persons with chronic illness.
Each item is rated 1-7, with 1 being "Terrible" and 7 being "Delighted".
Higher scores suggest the person may be experiencing a better quality of life.
Completed by patients before the interview.
The Center for Epidemiologic Studies Depression Scale is a 20-item survey that asks about depressive feelings and behaviours in the past week.
Each item is rated 0-3, with 0 being "Rarely or none of the time (less than 1 day)" and 3 being "Most or all of the time (5-7 days)".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed during the interview.
A review of systems is a checklist of medical problems.
Other Names:
Completed by patients.
The FACE-Q | Craniofacial - Appearance of the Face is a 9-item questionnaire.
Each item is rated 1-4, with 1 being "Not at All" and 4 being "Very Much".
Lower scores suggest the person may be less pleased with the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Appearance Distress is an 8-item questionnaire.
Each item is rated 1-4, with 1 being "Always" and 4 being "Never".
Lower scores suggest the person may be experiencing more distress related to the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Facial Function is a 10-item questionnaire.
Each item is rated 1-3, with 1 being "I cannot do this" and 3 being "I can do this".
Lower scores suggest the person may be experiencing more problems with facial muscle functioning.
|
Distal Arthrogryposis Type 1
Patients with features consistent with this diagnosis, including restricted movement in joints (contractures) of two or more body areas, often hands and feet, with fingers and toes frequently overlapping.
|
Review of medical records will be used, along with Guided Health History for Freeman-Burian Syndrome Questionnaire to assess patient histories and outcomes.
Other Names:
Completed by patients before the interview.
The PTSD Checklist for DSM-5 is a 20-item questionnaire.
Each item is rated 0-4, with 0 being "Not at all" and 4 being "Extremely".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed by patients before the interview.
The Modified Flanagan Quality of Life Scale is a 16-item survey designed for use in persons with chronic illness.
Each item is rated 1-7, with 1 being "Terrible" and 7 being "Delighted".
Higher scores suggest the person may be experiencing a better quality of life.
Completed by patients before the interview.
The Center for Epidemiologic Studies Depression Scale is a 20-item survey that asks about depressive feelings and behaviours in the past week.
Each item is rated 0-3, with 0 being "Rarely or none of the time (less than 1 day)" and 3 being "Most or all of the time (5-7 days)".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed during the interview.
A review of systems is a checklist of medical problems.
Other Names:
|
Distal Arthrogryposis Type 3
Patients with features consistent with this diagnosis, including: gap in the roof of the mouth (cleft palate); drooping eyelid (blepharoptosis); and spine curve problems; and restricted movement in joints (contractures) of two or more body areas, often hands and feet, with fingers and toes frequently overlapping.
|
Review of medical records will be used, along with Guided Health History for Freeman-Burian Syndrome Questionnaire to assess patient histories and outcomes.
Other Names:
Completed by patients before the interview.
The PTSD Checklist for DSM-5 is a 20-item questionnaire.
Each item is rated 0-4, with 0 being "Not at all" and 4 being "Extremely".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed by patients before the interview.
The Modified Flanagan Quality of Life Scale is a 16-item survey designed for use in persons with chronic illness.
Each item is rated 1-7, with 1 being "Terrible" and 7 being "Delighted".
Higher scores suggest the person may be experiencing a better quality of life.
Completed by patients before the interview.
The Center for Epidemiologic Studies Depression Scale is a 20-item survey that asks about depressive feelings and behaviours in the past week.
Each item is rated 0-3, with 0 being "Rarely or none of the time (less than 1 day)" and 3 being "Most or all of the time (5-7 days)".
Lower scores suggest the person may be experiencing fewer symptoms.
Completed during the interview.
A review of systems is a checklist of medical problems.
Other Names:
Completed by patients.
The FACE-Q | Craniofacial - Appearance of the Face is a 9-item questionnaire.
Each item is rated 1-4, with 1 being "Not at All" and 4 being "Very Much".
Lower scores suggest the person may be less pleased with the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Appearance Distress is an 8-item questionnaire.
Each item is rated 1-4, with 1 being "Always" and 4 being "Never".
Lower scores suggest the person may be experiencing more distress related to the appearance of their face.
Completed by patients.
The FACE-Q | Craniofacial - Facial Function is a 10-item questionnaire.
Each item is rated 1-3, with 1 being "I cannot do this" and 3 being "I can do this".
Lower scores suggest the person may be experiencing more problems with facial muscle functioning.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in intervention-related outcome rates between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Outcomes for all interventions are rated as either acceptable, unacceptable, or potentially harmful/harmful.
Information related to outcomes of interventions is collected using the Guided Health History for Freeman-Burian Syndrome Questionnaire, Review of Systems forms, and Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in diagnostic accuracy between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
This is the percent of patients with a stated diagnosis re-screened by study investigators with the same diagnosis.
Diagnostic information is collected using the Guided Health History for Freeman-Burian Syndrome Questionnaire and Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in posttraumatic stress disorder symptoms between groups
Time Frame: 1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Posttraumatic stress symptoms are assessed using the self-completed and validated PTSD Checklist for DSM-5, a 20-item questionnaire; each item is rated 0-4, with 0 being "Not at all" and 4 being "Extremely".
|
1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Difference in depressive symptoms between groups
Time Frame: 1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Depressive symptoms are assessed using the self-completed and validated Center for Epidemiologic Studies Depression Scale.
|
1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Difference in quality-of-life between groups
Time Frame: 1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Quality-of-life is scored using the self-completed Modified Flanagan Quality of Life Scale.
|
1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Difference in facial appearance satisfaction between groups
Time Frame: 1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Facial appearance satisfaction is scored using the self-completed FACE-Q | Craniofacial - Appearance of the Face.
|
1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Difference in facial appearance distress between groups
Time Frame: 1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Facial appearance distress is scored using the self-completed FACE-Q | Craniofacial - Appearance Distress.
|
1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Difference in facial muscle functioning symptoms between groups
Time Frame: 1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Facial muscle functioning symptoms are scored using the self-completed FACE-Q | Craniofacial - Facial Function.
|
1 week to 1 day before a single study interview, which lasts 1-2 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in diagnostic accuracy between specialities between all sub-types of Freeman-Burian syndrome and the other diagnosis groups (Sheldon-Hall syndrome, distal arthrogryposis type 3, and distal arthrogryposis type 1)
Time Frame: During a single study interview, which lasts 1-2 hours
|
Diagnostic accuracy is the percent of patients with a stated diagnosis re-screened by study investigators with the same diagnosis.
Specialities include: orthopedics, plastic surgery, anesthesia, pediatrics, and medical genetics.
Diagnostic information is collected using the Guided Health History for Freeman-Burian Syndrome Questionnaire and Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in head and face (craniofacial) surgery-related outcome rates between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Outcomes for all head and face (craniofacial) surgeries are rated as either acceptable, unacceptable, or harmful/potentially harmful.
Information related to outcomes of interventions is collected using the Guided Health History for Freeman-Burian Syndrome Questionnaire, Review of Systems forms, and Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in spine surgery-related outcome rates between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Outcomes for all spine surgeries are rated as either acceptable, unacceptable, or harmful/potentially harmful.
Information related to outcomes of interventions is collected using the Guided Health History for Freeman-Burian Syndrome Questionnaire, Review of Systems forms, and Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in foot and ankle surgery-related outcome rates between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Outcomes for all foot and ankle surgeries are rated as either acceptable, unacceptable, or harmful/potentially harmful.
Information related to outcomes of interventions is collected using the Guided Health History for Freeman-Burian Syndrome Questionnaire, Review of Systems forms, and Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in hand and wrist surgery-related outcome rates between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Outcomes for all hand and wrist surgeries are rated as either acceptable, unacceptable, or harmful/potentially harmful.
Information related to outcomes of interventions is collected using the Guided Health History for Freeman-Burian Syndrome Questionnaire, Review of Systems forms, and Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in other bone and joint surgery-related outcome rates between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Outcomes for other bone and joint surgeries are rated as either acceptable, unacceptable, or harmful/potentially harmful.
Information related to outcomes of interventions is collected using the Guided Health History for Freeman-Burian Syndrome Questionnaire, Review of Systems forms, and Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in general anesthesia-related complication rates between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
The course of general anesthesia-related is rated as either routine, minor, complication, major complication, or failure.
Information related to complications of interventions is collected using the Guided Health History for Freeman-Burian Syndrome Questionnaire, Review of Systems forms, and Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in respiratory-related complication rates between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Respiratory-related complications are assessed using the Guided Health History for Freeman-Burian Syndrome Questionnaire.
Additional information on physical findings is collected using the Review of Systems forms and from the Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in rates of difficulty eating (chewing and swallowing) between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Difficulty eating (chewing and swallowing) is assessed using the Guided Health History for Freeman-Burian Syndrome Questionnaire.
Additional information on physical findings is collected using the Review of Systems forms and from the Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Difference in rates of difficulty walking between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Difficulty walking is assessed using the Guided Health History for Freeman-Burian Syndrome Questionnaire.
Additional information on physical findings is collected using the Review of Systems forms and from the Medical Records Review.
|
During a single study interview, which lasts 1-2 hours
|
Qualitative difference in quality of life between groups
Time Frame: During a single study interview, which lasts 1-2 hours
|
Qualitative assessment is done using the Freeman-Burian syndrome Semi-Structured Quality of Life Interview, a guided interview consisting of open-ended questions.
|
During a single study interview, which lasts 1-2 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Craig R Dufresne, MD, Dr Craig R Dufresne, MD, PC
Publications and helpful links
General Publications
- Poling MI, Morales Corado JA, Chamberlain RL. Findings, phenotypes, and outcomes in Freeman-Sheldon and Sheldon-Hall syndromes and distal arthrogryposis types 1 and 3: protocol for systematic review and patient-level data meta-analysis. Syst Rev. 2017 Mar 6;6(1):46. doi: 10.1186/s13643-017-0444-4.
- Poling MI, Dufresne CR, Chamberlain RL. Dr Ben Franklin and an unusual modern-day cure for recurrent pleuritis. Br J Gen Pract. 2017 Jan;67(654):32-33. doi: 10.3399/bjgp17X688705. No abstract available.
- Poling MI, Dufresne CR. Head First, Not Feet First: Freeman-Sheldon Syndrome as Primarily a Craniofacial Condition. Cleft Palate Craniofac J. 2018 May;55(5):787-788. doi: 10.1177/1055665617753482. Epub 2018 Jan 25.
- Poling MI, Dufresne CR. Revisiting the Many Names of Freeman-Sheldon Syndrome. J Craniofac Surg. 2018 Nov;29(8):2176-2178. doi: 10.1097/SCS.0000000000004802.
- Poling MI, Dufresne CR, Chamberlain RL. Freeman-Burian syndrome. Orphanet J Rare Dis. 2019 Jan 10;14(1):14. doi: 10.1186/s13023-018-0984-2.
- Poling MI, Dufresne CR. Epidemiology, prevention, diagnosis, treatment, and outcomes for psychosocial problems in patients and families affected by non-intellectually impairing craniofacial malformation conditions: a systematic review protocol of qualitative data. Syst Rev. 2019 May 27;8(1):127. doi: 10.1186/s13643-019-1045-1.
- Poling MI, Dufresne CR. Freeman-Burian syndrome. Anasthesiologie und Intensivmedizin. 2019; 60(1): S8-S17. doi: 10.19224/ai2019.S008
- Poling MI, Dufresne CR, Portillo AL. Identification and Recent Approaches for Evaluation, Operative Counseling, and Management in Patients With Freeman-Burian Syndrome: Principles for Global Treatment. J Craniofac Surg. 2019 Nov-Dec;30(8):2502-2508. doi: 10.1097/SCS.0000000000005968.
- Poling MI, Dufresne CR. Distal arthrogryposis type 3. Anasthesiologie und Intensivmedizin. 2019; 60(13): S536-S543. doi: 10.19224/ai2019.s536.
- Poling MI, Dufresne CR. Identification and Recent Approaches for Evaluation and Management of Dentofacial and Otolaryngologic Concerns for Patients With Freeman-Burian Syndrome: Principles for Global Treatment. J Craniofac Surg. 2020 May/Jun;31(3):787-790. doi: 10.1097/SCS.0000000000006155.
- Poling MI, Dufresne CR, Chamberlain RL. Findings, Phenotypes, Diagnostic Accuracy, and Treatment in Freeman-Burian Syndrome. J Craniofac Surg. 2020 Jun;31(4):1063-1069. doi: 10.1097/SCS.0000000000006299.
- Poling MI, Dufresne CR, McCormick RJ. Identification and Recent Approaches for Evaluation and Management of Rehabilitation Concerns for Patients with Freeman-Burian Syndrome: Principles for Global Treatment. J Pediatr Genet. 2020 Sep;9(3):158-163. doi: 10.1055/s-0040-1710339. Epub 2020 May 7.
- Poling MI, Dufresne CR. Letter. AANA Journal. 2020; 88(5): 54.
- Poling MI, Dufresne CR. Letter: Precise Pulmonary Function Evaluation and Management of a Patient With Freeman-Sheldon Syndrome Associated With Recurrent Pneumonia and Chronic Respiratory Insufficiency (Ann Rehabil Med 2020;44:165-70). Ann Rehabil Med. 2020 Oct;44(5):409-410. doi: 10.5535/arm.20110. Epub 2020 Oct 29. No abstract available.
- Poling MI, Dufresne CR. Accuracy of facts about Freeman-Sheldon syndrome. Clinical and Experimental Obstetrics and Gynecolology. 2021; 48(5): 997-998. doi: 10.31083/j.ceog4805160
- Poling MI, Dufresne CR. Diagnosis, evaluation, and treatment in Freeman-Burian syndrome: clinical practice guideline for a rare and complex craniofacial syndrome. Craniomaxillofacial Abstracts Presented at 78th Annual Meeting of the American Cleft Palate Craniofacial Meeting. FACE. 2021; 2(4): NP3. doi: 10.1177/27325016211049488
- Poling MI, Dufresne CR. Clarity on Diagnosis in Freeman-Burian syndrome. Turkiye Klinikleri Journal of Case Reports. doi: 10.5336/caserep.2022-88270 [In Press] Available online: 17 February 2022. Available at: https://www.turkiyeklinikleri.com/inpress_article/en-clarity-on-diagnosis-in-freeman-burian-syndrome-97915.html
- Poling MI, Dufresne CR. Oculoplastic surgery, diagnosis, and other matters in Freeman-Burian syndrome. Ophthalmic Genet. 2022 Jun;43(3):431-432. doi: 10.1080/13816810.2022.2068043. Epub 2022 Apr 28. No abstract available.
- Poling MI, Dufresne CR. Anaesthesia recommendations for Sheldon-Hall syndrome. OrphanAnesthesia. 20 Feb 2019. Available at: https://www.orphananesthesia.eu/en/rare-diseases/published-guidelines/cat_view/61-rare-diseases/60-published-guidelines/237-sheldon-hall-syndrome.html
- Poling MI, Dufresne CR. Obstetrics and Diagnosis in Freeman-Burian syndrome. Version: 1. Authorea [preprint]. January 31, 2022. doi: 10.22541/au.164366820.09260728/v1.
- Poling MI, Dufresne CR. Misinformation and Misdiagnosis in Freeman-Burian syndrome. Version: 1. Authorea [preprint]. January 31, 2022. doi: 10.22541/au.164366815.52860865/v1.
- Poling MI, Dufresne CR. Limb Deformity Treatment and Diagnosis in Freeman-Burian syndrome. Version: 1. Authorea [preprint]. January 31, 2022. doi: 10.22541/au.164366820.05370920/v1.
- Poling MI, Dufresne CR. Unsafe Care and Misunderstanding Diagnosis in Freeman-Burian syndrome: Problems in Writing Case Reports Involving Rare Conditions and Strategies for Improvement. Authorea. January 24, 2022. doi: 10.22541/au.164303994.43963430/v1.
- Poling MI, Dufresne CR. The epidemiology, prevention, diagnosis, treatment, and outcomes of psychosocial problems in patients and families affected by non-intellectually impairing craniofacial malformation conditions. In: PROSPERO [Internet]. York, UK: Centre for Reviews and Dissemination University of York; 2018. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018093021. Other: CRD42018093021.
- Poling MI, Dufresne CR. Reply re: Periocular Anomalies in Freeman-Sheldon Syndrome. Version: 1. Authorea [preprint]. July 01, 2022. doi: 10.22541/au.165668902.20562659/v1
Helpful Links
- Principal Investigator's (Dr Craig R Dufresne) Research and Press Relations main webpage. Last Accessed: 7 Jun 2022
- "Freeman-Sheldon Syndrome" from the National Organization for Rare Disorders. Last Accessed: 10 Sept 2021
- Video about Freeman-Burian syndrome (previously known as Freeman-Sheldon syndrome) hosted by Genetic Alliance and presented by the Principal Investigator and Sub-Investigator (Craig R Dufresne and MI Poling). Last Accessed: 7 Jun 2022
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- U1111-1120-5851 (World Health Organisation, Universal Trial Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Freeman-Sheldon Syndrome
-
Freeman-Sheldon Research Group, Inc.TerminatedCraniofacial Abnormalities | Arthrogryposis | Freeman-Sheldon Syndrome | Arthrogryposis Distal Type 2A | Whistling Face Syndrome | Craniocarpotarsal Dysplasia | Craniocarpotarsal Dystrophy | Freeman-Sheldon Syndrome Variant | Sheldon-Hall Syndrome | Arthrogryposis Distal Type 2B | Gordon Syndrome | Arthrogryposis... and other conditionsUnited States
-
Freeman-Sheldon Research Group, Inc.WithdrawnCraniofacial Abnormalities | ArthrogryposisUnited States
-
Freeman-Sheldon Research Group, Inc.TerminatedDepressive Disorder | Craniofacial Abnormalities | Posttraumatic Stress Disorder | ArthrogryposisUnited States, Guatemala
-
Neumedicines Inc.Department of Health and Human ServicesCompletedHematopoietic Syndrome Due to Acute Radiation SyndromeUnited States
-
Ministry of Public Health, Democratic Republic...National Institutes of Health (NIH); Oregon Health and Science University; National... and other collaboratorsCompletedNeurotoxicity Syndrome, Cassava | Neurotoxicity Syndrome, Cyanate | Neurotoxicity Syndrome, Cyanide | Neurotoxicity Syndrome, ThiocyanateCongo, The Democratic Republic of the
-
Mahidol UniversityCompletedSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Subacromial Pain Syndrome | Subacromial Impingement | Impingement Syndrome, ShoulderIndonesia
-
Cliniques universitaires Saint-Luc- Université...TerminatedMultiple Organ Dysfunction Syndrome | SEPTIC SHOCK | SEPSIS SYNDROMEBelgium
-
University of PennsylvaniaRecruitingCRS - Cytokine Release Syndrome | HLHUnited States
-
University of ManitobaTerminatedPatellofemoral Pain Syndrome | Anterior Knee Pain Syndrome | Patellofemoral SyndromeCanada
-
Massachusetts General HospitalUniversity of California, San DiegoNot yet recruitingAuto-Brewery Syndrome | Gut Fermentation SyndromeUnited States
Clinical Trials on Guided Health History for Freeman-Burian Syndrome Questionnaire
-
Freeman-Sheldon Research Group, Inc.TerminatedCraniofacial Abnormalities | Arthrogryposis | Freeman-Sheldon Syndrome | Arthrogryposis Distal Type 2A | Whistling Face Syndrome | Craniocarpotarsal Dysplasia | Craniocarpotarsal Dystrophy | Freeman-Sheldon Syndrome Variant | Sheldon-Hall Syndrome | Arthrogryposis Distal Type 2B | Gordon Syndrome | Arthrogryposis... and other conditionsUnited States
-
University of MiamiWithdrawnProstate Cancer | Prostate AdenocarcinomaUnited States
-
Washington University School of MedicineEdward P. Evans FoundationRecruitingCardiovascular Diseases | Aged | Geriatrics | Geriatric SyndromesUnited States
-
Freeman-Sheldon Research Group, Inc.TerminatedDepressive Disorder | Craniofacial Abnormalities | Posttraumatic Stress Disorder | ArthrogryposisUnited States, Guatemala